Targeting angiogenesis driven by fibroblast growth factor using RPT835, an FGFR2 inhibitor.
Evgenia Stepanova
No relevant relationships to disclose
Eliso Solomko
No relevant relationships to disclose
Oxana Ryabaya
No relevant relationships to disclose
Nina Peretolchina
No relevant relationships to disclose
Ilya Tsimafeyeu
No relevant relationships to disclose
Sergei Tjulandin
No relevant relationships to disclose